Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Isobionics B V is managing 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 4 distinct examiners across 3 distinct art units. REGLAS, GEORGIANA C is the busiest examiner with 1 pending action.
This distribution shows a relatively wide prosecution footprint for the company current applications. With 4 pending office actions spread across 3 distinct art units, the portfolio demonstrates technical diversity within the biotechnology field. The involvement of 4 distinct examiners means that no single examiner is handling more than 1 case for the company at this time.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (75%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REGLAS, GEORGIANA C | 1 | 37.7% | +36.1% |
| JONES-FOSTER, ERICA NICOLE | 1 | 48.1% | +44.7% |
| EPSTEIN, TODD MATTHEW | 1 | 60.9% | +43.4% |
| RAGHU, GANAPATHIRAM | 1 | 73.6% | +26.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18717450 | RECOMBINANT MANUFACTURE OF SANTALENE | REGLAS, GEORGIANA C | — |
| 18681152 | ARTIFICIAL ALKANE OXIDATION SYSTEM FOR ALLYLIC OXIDATION OF A TERPENE SUBSTRATE | JONES-FOSTER, ERICA NICOLE | — |
| 18576769 | RECOMBINANT MANUFACTURE OF C-20 TERPENOID ALCOHOLS | EPSTEIN, TODD MATTHEW | — |
| 18007813 | SYNTHETIC SANTALENE SYNTHASES | RAGHU, GANAPATHIRAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18717450 | RECOMBINANT MANUFACTURE OF SANTALENE | REGLAS, GEORGIANA C | — |
| 18681152 | ARTIFICIAL ALKANE OXIDATION SYSTEM FOR ALLYLIC OXIDATION OF A TERPENE SUBSTRATE | JONES-FOSTER, ERICA NICOLE | — |
| 18576769 | RECOMBINANT MANUFACTURE OF C-20 TERPENOID ALCOHOLS | EPSTEIN, TODD MATTHEW | — |
| 18007813 | SYNTHETIC SANTALENE SYNTHASES | RAGHU, GANAPATHIRAM | — |
| Art Unit | Apps |
|---|---|
| 1652 | 2 |
| 1651 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18717450 | RECOMBINANT MANUFACTURE OF SANTALENE | REGLAS, GEORGIANA C | 1651 | §103§112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18681152 | ARTIFICIAL ALKANE OXIDATION SYSTEM FOR ALLYLIC OXIDATION OF A TERPENE SUBSTRATE | JONES-FOSTER, ERICA NICOLE | 1656 | §101§102§112 | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18576769 | RECOMBINANT MANUFACTURE OF C-20 TERPENOID ALCOHOLS | EPSTEIN, TODD MATTHEW | 1652 | §101§102§112 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18007813 | SYNTHETIC SANTALENE SYNTHASES | RAGHU, GANAPATHIRAM | 1652 | §101§102§112 | Final Rejection | — | Pending | Dec 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial